Dr. Weinreich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
624 Columbus Ave
Thornwood, NY 10594Phone+1 914-372-6111Fax+1 914-247-0160
Education & Training
University of MarylandResidency, Surgery, 1997 - 2001
Boston University School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2010 - 2026
NY State Medical License 2015 - 2026
MD State Medical License 2001 - 2017
VA State Medical License 2003 - 2004
Publications & Presentations
PubMed
- 5 citationsCasirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline...Andrea T Hooper, Selin Somersan-Karakaya, Shane E McCarthy, Eleftherios Mylonakis, Shazia Ali
Mbio. 2022-12-20 - 4 citationsReal-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large clai...Mohamed Hussein, Wenhui Wei, Vera Mastey, Robert J Sanchez, Degang Wang
BMJ Open. 2022-12-19 - 3 citationsEffectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19.Jessica J Jalbert, Mohamed Hussein, Vera Mastey, Robert J Sanchez, Degang Wang
Infectious Diseases and Therapy. 2022-12-01
Journal Articles
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19David Weinreich, MD, The New England Journal of Medicine
Abstracts/Posters
- Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)David M. Weinreich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple MyelomaDavid M. Weinreich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Regeneron's Yancopoulos Receives Columbia College's Alexander Hamilton AwardNovember 22nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
